Augmentation index in patients with different stages of hypertension
https://doi.org/10.15829/1728-8800-2020-2666
Abstract
Aim. To assess the augmentation index (AIx) in hypertensive patients depending on stages of hypertension (HTN).
Material and methods. Eighty-three people were examined: 62 patients with HTN and 21 patients of the control group. The subjects underwent a carotid duplex ultrasound and photoplethysmography to determine AIx. The results were processed using Statistica 10.0 software.
Results. Patients with HT were divided into 3 groups: stage I HTN (n=23); stage II HTN (n=18); stage III HTN (n=21). AIx was significantly higher in all groups of hypertensive patients compared to the control group. AIx levels were higher in the groups with a higher stage of HTN. Correlations were found between AIx and intima-media thickness (IMT) (r=0,676, p<0,05), the presence (r=0,496, p<0,05) and the number of atherosclerotic plaques (ASP) (r=0,56, p<0,05), carotid stenosis percentage (r=0,564, p<0,05). Multivariate analysis revealed that the Aix level is significantly affected only by age, INT and the presence of ASP. According to the ROC-analysis, stage I HTN are characterized by Alx levels from -0,8 to 1,4% (sensitivity, 87,5%; specificity, 55%), stage II — 1,4-18,5% (sensitivity, 71%; specificity, 57,3%), and stage III >18,5% (sensitivity, 85,4%; specificity, 53%).
Conclusion. With an increase in HTN stage, Alx significantly increases and directly correlates with IMT, the presence and amount of ASP, and the carotid stenosis percentage. The Alx level is influenced by age, IMT and the presence of ASP. ROC-analysis revealed the threshold values of Alx for each stage of hypertension.
About the Authors
V. I. Podzolkov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Moscow
Russian Federation
Moscow
A. E. Bragina
I.M. Sechenov First Moscow State Medical University
Russian Federation
Moscow
Russian Federation
Moscow
N. A. Druzhinina
I.M. Sechenov First Moscow State Medical University
Russian Federation
Moscow
Russian Federation
Moscow
D. A. Bayutina
I.M. Sechenov First Moscow State Medical University
Russian Federation
Moscow
Russian Federation
Moscow
References
1. 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Bull World Health Organ. 1993;71(5):503-17
2. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. doi:10.1093/eurheartj/ehy339.
3. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17:151-83.
4. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hyper-tension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;(6):1011-53. doi:10.1097/00004872-200306000-00001.
5. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;(6):1105-87 doi:10.1097/HJH.0b013e3281fc975a.
6. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219. doi:10.1093/eurheartj/eht151.
7. Korneva VA, Kuznetsova TYu. Evaluation of arterial wall stiffness indicators with daily monitoring of blood pressure. Therapeutic archive. 2016;9:119-24. (In Russ.) doi: 10.17116/terarkh2016889119-124.
8. Parfenov AS. Express-diagnostics of cardiovascular diseases. World of dimensions. 2008;7:4-11. (In Russ.)
9. Podzolkov VI, Bragina AE, Druzhinina NA. Prognostic significance of endothelial dysfunction markers in arterial hypertension. Russ J Cardiol. 2018;(4):7-13. (In Russ.) doi:10.15829/1560-4071-2018-4-7-13.
10. Musikhina NA, Gapon LI, Petelina TI, et al. Endothelial dysfunction and heart rate variability in patients with arterial hypertension and coronary artery disease. Arterial Hypertension. 2016;22(4):414-24. (In Russ.) doi:10.18705/1607-419X-2016-22-4-414-424.
11. Polupanov AG, Mamasaidov JA, Geleskhanova YN, et al. Arterial stiffness and carotid arteries: correlation with daily blood pressure profile in essential hypertension. Arterial Hypertension. 2015; 21(6):577-86. (In Russ.) doi:10.18705/1607-419X-2015-21-6-577-586.
12. Pannier BM, Guerin AP, Marchais SJ, et al. Different aortic reflection wave responses following long-term angiotensinconverting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol. 2001;28(12):1074-7 doi:10.1046/j.1440-1681.2001.03570.x.
13. Evsevyeva ME, Sergeeva OV, Dobroselskiy VN et al. Central aortic pressure and augmentation index in young adults with regard to cardiovascular risk factors. Arterial Hypertension. 2015;21(1):59-68. (In Russ.) doi:10.18705/1607-419X-2015-21-1-59-68.
14. Kusunoki H, Iwashima Y, Kawano Y, et al. Association between circadian hemodynamic characteristics and target organ damage in patients with essential hypertension. Am J Hypertens. 2019;32(8):742-51. doi:10.1093/ajh/hpz088.
15. Li WF, Huang YQ, Feng YQ. Association between central haemodynamics and risk of all-cause mortality and cardiovascular disease: a systematic review and meta-analysis. J Hum Hypertens. 2019;33(7):531-41. doi:10.1038/s41371-019-0187-x.
16. Ghosh A, Dharmarajan A, Swain PK, et al. Impact of cardiovascular factors on pulse wave velocity and total vascular resistance in different age group patients with cardiovascular disorders. Curr Aging Sci. 2019;11(4):261-8. doi:10.2174/1874609812666190226151500.
17. 17 Nardin C, Maki-Petaja KM, Miles KL, et al. Cardiovascular Phenotype of Elevated Blood Pressure Differs Markedly Between Young Males and Females: The Enigma Study. Hypertension. 2018;72(6):1277-84. doi:10.1161/HYPERTENSIONAHA.118.11975.
Review
For citations:
Podzolkov V.I., Bragina A.E., Druzhinina N.A., Bayutina D.A. Augmentation index in patients with different stages of hypertension. Cardiovascular Therapy and Prevention. 2020;19(5):2666. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2666
Views:
1925
Email this article 
